Arend; Michael P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arend; Michael P..The latest application filed is for "methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylase".

Company Profile

10.40.58

Arend; Michael P. - Foster City CA
- Foster City CA US
Arend; Michael P. - San Mateo CA US
Arend; Michael P. - Forster City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 11,229,637 - Arend , et al. January 25, 2	2022-01-25
Methods For Treating Anemia In Subjects Having Kidney Failure Using Inhibitors Of Hypoxia-inducible Factor (hif) Hydroxylase App 20210369702 - KLAUS; Stephen J. ; et al.	2021-12-02
Enhanced Erythropoiesis And Iron Metabolism App 20210107878 - Klaus; Stephen J. ; et al.	2021-04-15
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20210060000 - Arend; Michael P. ; et al.	2021-03-04
Enhanced erythropoiesis and iron metabolism Grant 10,927,081 - Klaus , et al. February 23, 2	2021-02-23
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 10,646,482 - Arend , et al.	2020-05-12
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20200115344 - Witschi; Claudia ; et al.	2020-04-16
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20190276408 - Witschi; Claudia ; et al.	2019-09-12
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20190240213 - Arend; Michael P. ; et al.	2019-08-08
Crystalline forms of a prolyl hydroxylase inhibitor Grant 10,272,078 - Witschi , et al.	2019-04-30
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20190022080 - Witschi; Claudia ; et al.	2019-01-24
Crystalline forms of a prolyl hydroxylase inhibitor Grant 10,118,897 - Witschi , et al. November 6, 2	2018-11-06
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 10,092,558 - Arend , et al. October 9, 2	2018-10-09
Crystalline forms of a prolyl hydroxylase inhibitor Grant 9,918,977 - Witschi , et al. March 20, 2	2018-03-20
Methods For Treating A Neurological Disorder In A Subject Using Inhibitors Of Hypoxia-inducible Factor (hif) Proyl Hydroxylase App 20170312268 - KLAUS; Stephen J. ; et al.	2017-11-02
Process for making isoquinoline compounds Grant 9,708,269 - Thompson , et al. July 18, 2	2017-07-18
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20170190667 - Witschi; Claudia ; et al.	2017-07-06
Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase Grant 9,695,170 - Ng , et al. July 4, 2	2017-07-04
Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-a- cetic acid Grant 9,643,928 - Witschi , et al. May 9, 2	2017-05-09
Crystalline forms of a prolyl hydroxylase inhibitor Grant 9,617,218 - Witschi , et al. April 11, 2	2017-04-11
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20170035747 - Arend; Michael P. ; et al.	2017-02-09
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20160331741 - Witschi; Claudia ; et al.	2016-11-17
4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors Grant 9,409,892 - Ho , et al. August 9, 2	2016-08-09
Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity Grant 9,387,200 - Zhou , et al. July 12, 2	2016-07-12
Process For Making Isoquinoline Compounds App 20160194285 - Thompson; Michael D. ; et al.	2016-07-07
Crystalline forms of a prolyl hydroxylase inhibitor Grant 9,371,288 - Witschi , et al. June 21, 2	2016-06-21
Naphthyridine Derivatives As Inhibitors Of Hypoxia Inducible Factor (hif) Hydroxylase App 20160159796 - Ng; Danny ; et al.	2016-06-09
Process for making isoquinoline compounds Grant 9,340,511 - Thompson , et al. May 17, 2	2016-05-17
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 9,339,527 - Arend , et al. May 17, 2	2016-05-17
Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase Grant 9,271,970 - Ng , et al. March 1, 2	2016-03-01
Crystalline Forms Of -acetic Acid App 20160002170 - WITSCHI; Claudia ; et al.	2016-01-07
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20150322015 - Witschi; Claudia ; et al.	2015-11-12
Crystalline forms of a prolyl hydroxylase inhibitor Grant 9,115,085 - Witschi , et al. August 25, 2	2015-08-25
Isothiazole-pyridine Derivatives As Modulators Of Hif (hypoxia Inducible Factor) Activity App 20150209336 - Zhou; Xiaoti ; et al.	2015-07-30
Naphthyridine Derivatives As Inhibitors Of Hypoxia Inducible Factor (hif) Hydroxylase App 20150174110 - Ng; Danny ; et al.	2015-06-25
Process For Making Isoquinoline Compounds App 20150175550 - Thompson; Michael D. ; et al.	2015-06-25
Thienopyridine compounds, and methods of use thereof Grant 9,000,006 - Turtle , et al. April 7, 2	2015-04-07
Methods For Treating Anemia In Subjects Having Kidney Failure Using Inhibitors Of Hypoxia-inducible Factor (hif) Hydroxylase App 20150080425 - KLAUS; STEPHEN J. ; et al.	2015-03-19
Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity Grant 8,952,160 - Zhou , et al. February 10, 2	2015-02-10
4 -hydroxy- Isoquinoline Compounds As Hif Hydroxylase Inhibitors App 20150038528 - Ho; Wen-Bin ; et al.	2015-02-05
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20150038529 - Witschi; Claudia ; et al.	2015-02-05
Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase Grant 08921389 -	2014-12-30
Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase Grant 8,921,389 - Ng , et al. December 30, 2	2014-12-30
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 8,916,585 - Arend , et al. December 23, 2	2014-12-23
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20140343094 - Arend; Michael P. ; et al.	2014-11-20
Crystalline forms of a prolyl hydroxylase inhibitor Grant 8,883,823 - Witschi , et al. November 11, 2	2014-11-11
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20140303202 - Witschi; Claudia ; et al.	2014-10-09
Novel Thienopyridine Compounds, And Methods Of Use Thereof App 20140221422 - Turtle; Eric D. ; et al.	2014-08-07
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 8,765,956 - Arend , et al. July 1, 2	2014-07-01
Cyanoisoquinoline compounds and methods of use thereof Grant 8,759,373 - Arend , et al. June 24, 2	2014-06-24
Thienopyridine compounds, and methods of use thereof Grant 8,703,795 - Turtle , et al. April 22, 2	2014-04-22
Naphthyridine Derivatives As Inhibitors Of Hypoxia Inducible Factor (hif) Hydroxylase App 20140088101 - Ng; Danny ; et al.	2014-03-27
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20140024676 - Witschi; Claudia ; et al.	2014-01-23
Crystalline Forms Of A Prolyl Hydroxylase Inhibitor App 20140024675 - Witschi; Claudia ; et al.	2014-01-23
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20130310565 - Arend; Michael P. ; et al.	2013-11-21
Stabilization of Hypoxia Inducible Factor (HIF) Alpha App 20130245037 - Guenzler-Pukall; Volkmar ; et al.	2013-09-19
Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase App 20130203805 - Klaus; Stephen J. ; et al.	2013-08-08
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20130178417 - AREND; Michael P. ; et al.	2013-07-11
Stabilization of hypoxia inducible factor (HIF) alpha Grant 8,466,172 - Guenzler-Pukall , et al. June 18, 2	2013-06-18
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 8,278,325 - Arend , et al. October 2, 2	2012-10-02
Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditions Grant 8,269,008 - Arend , et al. September 18, 2	2012-09-18
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20120029011 - Arend; Michael P. ; et al.	2012-02-02
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 8,017,625 - Arend , et al. September 13, 2	2011-09-13
Cyanoisoquinoline Compounds and Methods of Use Thereof App 20110212959 - Arend; Michael P. ; et al.	2011-09-01
Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase App 20110166178 - Klaus; Stephen J. ; et al.	2011-07-07
Stabilization of hypoxia inducible factor (HIF) alpha App 20110166145 - Guenzler-Pukall; Volkmar ; et al.	2011-07-07
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 7,863,292 - Arend , et al. January 4, 2	2011-01-04
Isothiazole-pyridine Derivates As Modulators Of Hif (hypoxia Inducible Factor) Activity App 20100330199 - Zhou; Xiaoti ; et al.	2010-12-30
Isoxazolopyridine Derivatives For Use In The Treatment Of Hif-mediated Conditions App 20100303928 - Arend; Michael P. ; et al.	2010-12-02
Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof Grant 7,696,223 - Deng , et al. April 13, 2	2010-04-13
Nitrogen-containing heteroaryl compounds and methods of user thereof Grant 7,629,357 - Arend , et al. December 8, 2	2009-12-08
Novel Nitrogen-containing Heteroaryl Compounds And Methods Of Use Thereof App 20080293763 - Arend; Michael P. ; et al.	2008-11-27
Nitrogen-containing heteroaryl compounds and methods of use thereof Grant 7,323,475 - Arend , et al. January 29, 2	2008-01-29
Pyrrolo- And Thiazolo-pyridine Compounds, And Methods Of Use Thereof App 20080004309 - DENG; Shaojiang ; et al.	2008-01-03
Novel Nitrogen-Containing Heteroaryl Compounds And Methods of Use Thereof App 20070185159 - AREND; Michael P. ; et al.	2007-08-09
Novel nitrogen-containing heteroaryl compounds and methods of use thereof App 20070155784 - Arend; Michael P. ; et al.	2007-07-05
Stabilization of hypoxia inducible factor (HIF) alpha App 20060270699 - Guenzler-Pukall; Volkmar ; et al.	2006-11-30
Stabilization of hypoxia inducible factor (HIF) alpha App 20060258660 - Guenzler-Pukall; Volkmar ; et al.	2006-11-16
Stabilization of hypoxia inducible factor (HIF) alpha App 20060258702 - Guenzler-Pukall; Volkmar ; et al.	2006-11-16
Novel nitrogen-containing heteroaryl compounds and methods of use thereof App 20060217416 - Arend; Michael P. ; et al.	2006-09-28
Novel thienopyridine compounds, and methods of use thereof App 20060199836 - Turtle; Eric D. ; et al.	2006-09-07
Methods of increasing endogenous erythropoietin (EPO) App 20060183695 - Klaus; Stephen J. ; et al.	2006-08-17
Methods of increasing endogenous erythropoietin (EPO) App 20060178316 - Klaus; Stephen J. ; et al.	2006-08-10
Methods of increasing endogenous erythropoietin (EPO) App 20060178317 - Klaus; Stephen J. ; et al.	2006-08-10
Novel nitrogen-containing heteroaryl compounds and methods of use thereof App 20040254215 - Arend, Michael P. ; et al.	2004-12-16
Stabilization of hypoxia inducible factor (HIF) alpha App 20030176317 - Guenzler-Pukall, Volkmar ; et al.	2003-09-18
Methods of increasing endogenous erythropoietin (EPO) App 20030153503 - Klaus, Stephen J. ; et al.	2003-08-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.